Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery
This study has been completed.
Sponsor:
Bp Consulting, Inc
Information provided by (Responsible Party):
Bp Consulting, Inc
ClinicalTrials.gov Identifier:
NCT00758199
First received: September 22, 2008
Last updated: March 14, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2010 |
| Primary Completion Date: | January 2010 (Final data collection date for primary outcome measure) |